Get started

NNOX

All Red - $NNOX Long - But Nanox's Biggest Issue Right NowThe problem with Nanox, which is also likely why they recently had a stock sale, is likely the need of cash for further distribution. They are in the red and still have long ways to go. That said, when the market dips, Nanox seriously dips. Beyond just the recent France deal, a catalyst is needed to further push Nanox further. That said, I believe we could be long overdue for a bull run. As always, none of this is investment or financial advice. Please do your own due diligence and research.
NASDAQ:NNOXLong
by gamer456148
My Sentiment for $NNOX is Still LongNanox Imaging is one of those stocks I lost long term in, and kind of got attached to. However, my sentiment based on their tech and acquisitions is still long. The biggest issue is short sale volume, the need for better PR and faster project updates, the loss of their founder, and uncertainty of the future of Nanox Imaging along with the high risk in biotech. $18.41 as a target by 2027 is still feasible, however, NASDAQ:NNOX has to deliver. They have long ways to go to revamp their brand image after what happened with short sellers. As always, none of this is investment or financial advice. Please do your own due diligence and research.
NASDAQ:NNOXLong
by gamer456148
Can X-Ray Technology Really Disrupt a 125-Year-Old Industry?Nano-X Imaging is attempting to fundamentally restructure the medical imaging industry through a convergence of semiconductor innovation and business model disruption. The company has commercialized a cold cathode X-ray source that replaces the century-old thermionic emission technology, which wastes 99% of energy as heat, with field emission from millions of molybdenum nano-cones operating at room temperature. This breakthrough, manufactured in their South Korean semiconductor fabrication facility near the SK Hynix cluster, enables the Nanox.ARC system: a compact, digitally-agile tomosynthesis device that eliminates the need for massive cooling systems and rotating gantries that have defined traditional CT scanners.   The commercial strategy centers on "Medical Screening as a Service" (MSaaS), converting imaging from a capital expenditure to an operational expense, which is particularly advantageous in the current high-interest-rate environment, where hospitals face capital budget constraints. Strategic partnerships provide immediate market access: the 3DR Labs agreement connects Nanox to over 1,800 US hospitals, integrating FDA-cleared AI algorithms (HealthCCSng, HealthOST, HealthFLD) directly into existing radiology workflows, while international deployments span Mexico (630 units with SPI Medical), South Korea and Vietnam (2,500 systems supported by SK Telecom), and European reference sites in France. Management has issued ambitious guidance of $35 million in revenue for 2026, representing approximately 900% growth from 2025 levels, progressing toward a projected $72.6 million by 2028.   The investment thesis rests on technological validation (FDA 510(k) clearance, operational semiconductor fab), geopolitical resilience (supply chain decoupled from Middle East instability), and macroeconomic alignment (OpEx-based model favored during capital constraints). However, execution risks remain significant: the company maintains a substantial cash burn rate ($30.4 million in negative operating cash flow), requires continued capital raises (most recently, a $15 million offering), and faces adoption uncertainty as hospitals evaluate this novel service model. Analyst sentiment is bullish with price targets averaging $7.75 (120%+ upside), though more aggressive projections reach $23, contingent on the successful scaled deployment of the recurring revenue model that fundamentally challenges the traditional equipment sales paradigm of incumbent manufacturers like GE, Siemens, and Philips.
NASDAQ:NNOXLong
by UDIS_View
NNOX Bull Run on FDA Clearance ( Med Tech)NNOX on the 15 minute chart is on a 100% move due to FDA clearance of its new 3D technology for Xrays. This will revolutionize Xrays for the medical field like MRIs did when they come out compared with CT Scan. This is an Israeli company whose technology will be inexpensive and will potentially be adapted globally. The market is measured in multiple billions $$$. The chart is self evident. Notable, is the volume spike corresponding to the price action. I will buy a large quantity of call options DTE about 90-120 and scale out gradually and unrealized profits are shown.
NASDAQ:NNOXLong
by AwesomeAvani
1
OCGN pumps on dismissal of investor lawsuit LONGOCGN has been a great swing trade after buying bad news. The good news has replaced the bad. Earnings are in three days. Price well below ATH. November earnings were a beat meaning this risky Med Tech penny stock had a lower cash burn than projected. Now legal costs will disappear. Going long with a decent position expecting a better earnings. In law, the Latin phrase res ipsa loquitur is sometimes used. Here it aptly applies to Ocugen.
NASDAQ:OCGNLong
by AwesomeAvani
1
$NNOX Receives FDA 510K, Next Big Catalyst?The stock that I like so much finally received FDA 510K on the Nanox.ARC X-ray system. As much as it been short-selled into the ground, I am still heavily invested in it, and I think many of the catalyst in terms of early market and tech validation have already passed. It may not be smooth sailing, but I am still interested in Nanox for the long term, and am still here. That said, none of this is financial or investment advice. Information provided is "as-is". Do your own due-diligence.
NASDAQ:NNOXLong
by gamer456148
1
Could $NNOX have hit a Triple Bottom --> Potential Long?$NNOX is one of those stocks that been giving everybody (including myself) a difficult time. They have been massively short-selled and as a result, people have been extra critical on the buyside. However, as far as I am concerned, version #1 got FDA 510K, they are acquiring Zebra Medical, they are finishing up the build of their factory, and the charting pattern looks very similar to a triple bottom. That said, invest at your own risk. Please consider this on an opinion-based basis.
NASDAQ:NNOXLong
by gamer456148
NNOX, Ready for Round #4?I think Nanox has been heavily shortened on FDA news, which isn't surprising knowing the market's tricks. That said, it is accumulating and has been around the $33 price point for the past few days. I think now is the time where for the next few weeks, support levels can start picking up. It does have potential for a next wave bull run at these levels, and a real short squeeze is yet to happen in my opinion. That said, everything I say is on an opinion based basis. Invest at your own risk and do your own due diligence.
NASDAQ:NNOXLong
by gamer456148
2
2nd opportunity !Last time I spotted the +80% move in less than 2 wks. It could be the second opportunity for those who missed the first one! Potential gain: 80-140% Reward/Risk:4-7 Timeframe: up to 1 year I always try to present the charts in a simple comprehensive format to prevent any confusion. This is just my technical view, neither a fundamental comment,nor a recommendation to trade..! Please review my track record and calculate the odds for yourself..! You’re likes and comments encourage me to continue this. Stay tuned great live stream and quality content videos coming soon..!
NASDAQ:NNOXLong
by Moshkelgosha
7
US Stock In Play: $NNOX (Nano-X Imaging Ltd.)With Wall Street’s attention fully focused on the exasperation and parabolic price behavior of $GME, $BB, $BBNY and $AMC this week, $NNOX have slipped under the media radar with a +65% rally since Friday, breaking out of its consolidated price action within a Symmetrical Triangle chart pattern. $NNOX closed at $85.13, posting a new all-time high for the first time since December 2020. $NNOX price rally with coupled with infusion of significant liquidity, where trading volume returns to a level that was last witnessed in November 2020. Current price volatility have surge to a day range of $7.13, barely a dollar away from its peak volatility established in September 2020.
NASDAQ:NNOXLong
by jfsrev
$NNOX, Wait for the Catalyst + Short Squeeze (Low Volume)Nanox has been shortened alot, and now oversold on low volume. Looking at the RSI, it is quite low, and due for a breakout. Outside of this, I believe it has been announced that they have pre-orders for within the range of 15k machines. This accounts to what could be $1 billion in mostly revenue, if I understand currently from what has been said about the JP Morgan Virtual Conference. At the current market cap of $2.3B, this puts them likely under their fair overall enterprise value. Currently, FDA approval is a major catalyst that should be "soon" in regards to single source if everything goes well. Multi-source could be in the first half of 2021. It is currently a waiting game in regards to catalyst. There are also other big catalyst such as a factory announcement that may happen soon. Regarding patterns, I think overall a bullish setup is there. Currently, I am long. That said, do your own due diligence and invest at your own risk.
NASDAQ:NNOXLong
by gamer456148
2
The $115+ NNOX Target + Patterns$NNOX is one of those volatile stocks that took the world by storm. If you don't like volatility, it is likely best to stay away from biotech or healthcare. That said, there are alot of expected catalysts. $NNOX have been heavily shortened, and it is in the opinion of many that lots of market manipulation has been and is going on. The short interest is low and the borrow rate is high. Currently as I see it, the pattern is still incrementally upwards. Nanox has the catalyst of factory announcements, FDA approvals for both single and multisource, plus the commencement of "device leasing". Currently with 4 catalyst, three of them that are expected to be big, a target of $115 seems reasonable. Support levels should be picking up soon, and unless one wants to flip for few cents or dollars per share as profit, this currently seems much better suited for a long term position. That said, I am long. Everything I say is on an opinion based basis. Please do your own due diligence and proceed with caution. Opinions mentioned here aren't meant to warrant solicited financial advice.
NASDAQ:NNOXLong
by gamer456148